Comparative Study on the Immunogenicity and Efficacy of Different Post-exposure Intramuscular Rabies Vaccination Regimens in China

被引:0
|
作者
SONG Yun [1 ]
HE Ying [2 ]
LU Xue Xin [2 ]
ZHANG Xiao Mei [3 ]
JIANG XIAO Lin [3 ]
SONG Qing [4 ]
HUANG Xue Yong [1 ]
MA Hong Xia [1 ]
YU Peng Cheng [2 ]
ZHU Wu Yang [2 ]
机构
[1] Henan Provincial Center for Disease Control and Prevention,Infectious Disease Prevention and Control Institute,Henan Provincial Key Laboratory of Infectious Disease Pathogens
[2] National Institute for Viral Disease Control and Prevention,China CDC,Key Laboratory of Biosafety,National Health Commission
[3] Shandong Provincial Center for Disease Control and Prevention
[4] Qingdao Chengyang District Center for Disease Control and Prevention
关键词
D O I
暂无
中图分类号
R186 [预防接种、计划免疫、药物预防];
学科分类号
100401 ;
摘要
Objective This study aimed to compare the current Essen rabies post-exposure immunization schedule(0-3-7-14-28) in China and the simple 4-dose schedule(0-3-7-14) newly recommended by the World Health Organization in terms of their safety, efficacy, and protection.Methods Mice were vaccinated according to different immunization schedules, and blood was collected for detection of rabies virus neutralizing antibodies(RVNAs) on days 14, 21, 28, 35, and 120after the first immunization. Additionally, different groups of mice were injected with lethal doses of the CVS-11 virus on day 0, subjected to different rabies immunization schedules, and assessed for morbidity and death status. In a clinical trial, 185 rabies-exposed individuals were selected for post-exposure vaccination according to the Essen schedule, and blood was collected for RVNAs detection on days 28and 42 after the first immunization.Results A statistically significant difference in RVNAs between mice in the Essen and 0-3-7-14 schedule groups was observed on the 35th day(P < 0.05). The groups 0-3-7-14, 0-3-7-21, and 0-3-7-28 showed no statistically significant difference(P > 0.05) in RVNAs levels at any time point. The post-exposure immune protective test showed that the survival rate of mice in the control group was 20%, whereas that in the immunization groups was 40%. In the clinical trial, the RVNAs positive conversion rates on days 28(14 days after 4 doses) and 42(14 days after 5 doses) were both 100%, and no significant difference in RVNAs levels was observed(P > 0.05).Conclusion The simple 4-dose schedule can produce sufficient RVNAs levels, with no significant effect of a delayed fourth vaccine dose(14–28 d) on the immunization potential.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 50 条
  • [31] Intradermal Rabies Vaccination: The Evolution and Future of Pre- and Post-exposure Prophylaxis
    Warrell, M. J.
    INTRADERMAL IMMUNIZATION, 2012, 351 : 139 - 157
  • [32] ANTIBODY-TITERS FOLLOWING PROPHYLACTIC AND POST-EXPOSURE VACCINATION AGAINST RABIES
    HEFTI, J
    KELLER, H
    GEISER, M
    GERBER, H
    WANDELER, A
    STECK, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1979, 109 (14) : 509 - 516
  • [33] Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine
    Kamoltham, T
    Khawplod, P
    Wilde, H
    VACCINE, 2002, 20 (27-28) : 3272 - 3276
  • [34] Assessing safety and immunogenicity of post-exposure prophylaxis following interchangeability of rabies vaccines in humans
    Ravish, Hardanahalli S.
    Sudarshan, Mysore K.
    Madhusudana, Shampur N.
    Annadani, Rachana R.
    Narayana, Doddabele H. Ashwath
    Belludi, Ashwin Y.
    Anandaiah, Gangaboraiah
    Vijayashankar, Veena
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1354 - 1358
  • [35] Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis
    Xu, Chang
    Lau, Colleen L.
    Clark, Justin
    Rafferty, Anna C.
    Mills, Deborah J.
    Ramsey, Lani
    Gilbert, Brian
    Doi, Suhail A. R.
    Furuya-Kanamori, Luis
    VACCINE, 2021, 39 (07) : 1044 - 1050
  • [36] RABIES IMMUNOSOME (SUBUNIT VACCINE) STRUCTURE AND IMMUNOGENICITY - PRE-EXPOSURE AND POST-EXPOSURE PROTECTION STUDIES
    PERRIN, P
    THIBODEAU, L
    SUREAU, P
    VACCINE, 1985, 3 (03) : 325 - 332
  • [37] Post-exposure prophylaxis vaccination rate and risk factors of human rabies in mainland China: a meta-analysis
    Wang, D. L.
    Zhang, X. F.
    Jin, H.
    Cheng, X. Q.
    Duan, C. X.
    Wang, X. C.
    Bao, C. J.
    Zhou, M. H.
    Ahmad, T.
    EPIDEMIOLOGY AND INFECTION, 2019, 147
  • [38] Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children
    Chulasugandha, P
    Khawplod, P
    Havanond, P
    Wilde, H
    VACCINE, 2006, 24 (09) : 1478 - 1482
  • [39] Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination
    Sirikun, Jatuporn
    Suputtamongkol, Yupin
    Rattanachinakorn, Ploypailin
    Primsirikunawut, Athiwat
    VACCINE, 2018, 36 (02) : 285 - 291
  • [40] Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia
    Lang, J
    Simanjuntak, GH
    Soerjosembodo, S
    Koesharyono, C
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1998, 76 (05) : 491 - 495